Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Mayors get the £500m grant pen

2 min read
16:30UTC

DSIT handed seven city-region mayors direct control of the £500m Local Innovation Partnerships Fund on 1 June, moving allocation power from a Whitehall committee to elected regional leaders, with Liverpool first to draw £23.7m.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

Innovation spending power moves from Whitehall grant committees to elected regional mayors for the first time.

The Department for Science, Innovation and Technology (DSIT) announced on Monday 1 June that seven city-region mayors will gain direct control of Local Innovation Partnerships Fund (LIPF) allocations after the 2027 Spending Review. The mayors of Liverpool City Region, West Yorkshire, South Yorkshire, Greater Manchester, the North East, Greater London and the West Midlands will decide where the money lands in their patches.⁠1

The fund runs to £500m across 17 English regions for 2026 to 2031, part of an £86bn research-and-development settlement to 2030. Until now a central department ranked bids and rationed grants; the mayors will set regional priorities themselves, on the argument that they read local research strengths better than a London committee does. The first projects went to the University of Liverpool: £23.7m, split £15m to an artificial-intelligence and materials programme and £8.7m to work on AI-designed antimicrobial surfaces.

DSIT had already been steering money northward through other channels. AI Growth Zones directed data-centre capacity toward Scotland and the north of England, and the department's life-sciences manufacturing grants went to four sites outside the Oxford-Cambridge-London triangle in April. Devolving the LIPF moves the decision itself out of Whitehall rather than redistributing money a committee still controls.

Deep Analysis

In plain English

The UK government spends billions each year on research grants to universities and companies. Until now, most decisions about where that money goes were made by Whitehall civil servants and UKRI committees, whose members are disproportionately drawn from the Oxford-Cambridge-London university triangle. The £500m Local Innovation Partnerships Fund is being handed to seven city-region mayors. Each mayor will decide how their allocation is spent within their region, within DSIT guidelines. The first £23.7m went to the University of Liverpool for two AI programmes. The practical effect: a mayor with a strong manufacturing base can direct grants to advanced manufacturing research. A mayor whose region has a pharmaceutical cluster can fund life sciences. The allocation no longer flows automatically to the institutions with the most prestigious track record.

Deep Analysis
Root Causes

UK innovation concentration is self-reinforcing: Oxford, Cambridge, and London attract talent because research funding goes there; research funding goes there because talent is there. Breaking the cycle requires a structural intervention on the funding side, which individual grant decisions cannot achieve.

The 2027 Spending Review timeline matters for incentives: mayors gain allocation authority only after the Review, giving DSIT two years to monitor whether the current pattern of pre-devolution spending (first £23.7m to Liverpool) establishes a geographic norm before control transfers.

Combined authority mayors (Andy Burnham in Manchester, Tracy Brabin in West Yorkshire) have stronger electoral bases than any individual MP and can absorb the political cost of funding a competitor city's university if the overall pot is managed regionally.

What could happen next?
  • Consequence

    The seven mayors will have direct institutional incentives to grow their regional university research capacity in the run-up to the 2027 Spending Review, when their formal LIPF authority begins.

    Short term · Reported
  • Risk

    If LIPF funds concentrate in the strongest single institution per region (replicating the RDA capture pattern), the geographic rebalancing rationale does not hold and the policy case for further devolution weakens.

    Medium term · Assessed
  • Opportunity

    For deep-tech companies headquartered outside the Golden Triangle, LIPF-funded university research programmes create a new route to partially-subsidised R&D partnerships that were previously inaccessible.

    Medium term · Assessed
Sources:GOV.UK / DSIT·GOV.UK / DSIT·GOV.UK / DSIT
Mentions:DSIT →UKRI →Institute for Fiscal Studies →OECD →Whitehall →London →AI Growth Zones →Germany →Cambridge →England →Local Innovation Partnerships Fund →University of Liverpool →Andy Burnham →Greater Manchester →
First Reported In

Update #7 · OQC's £260m sets European quantum record

GOV.UK / DSIT· 7 Jun 2026
Read original →
Causes and effects
Caused by
Slough saturates, AI datacentres head north
AI Growth Zones pushing capacity north provided the political context for DSIT devolution of LIPF to regional mayors.
Occurred 20 Apr 2026
Read story →
LSIMF sends £80m+ to four regional sites
DSIT life-sciences grants going to four non-Golden-Triangle sites in April set a precedent for the LIPF devolution to city-region mayors.
Occurred 14 Apr 2026
Read story →
This Event
Mayors get the £500m grant pen
For the first time, elected mayors rather than civil servants decide where £500m of research money lands in their regions.
Led to
Midlands fund writes its first cheques
Midlands Mindforge's first deployments echo the £500m LIPF devolution DSIT handed to seven city-region mayors at the start of June, both chipping at Golden Triangle concentration.
Occurred 10 Jun 2026
Read story →
Innovate UK puts £27m in offshore wind
DSIT's £500m LIPF devolution to city-region mayors reflects the same regional-push instinct that Innovate UK's Isle of Wight LSIC investment embodies.
Occurred 16 Jun 2026
Read story →
London's equity share slips to 57%
DSIT's GBP500m LIPF devolution to city-region mayors builds regional investment capacity beneath the tracker's headline shifts.
Occurred 1 Jul 2026
Read story →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.